MedPath

PINOT Follow-up Study in End-stage Kidney Disease

Completed
Conditions
Chronic Kidney Disease
Interventions
Procedure: dialysis, kidney transplant
Registration Number
NCT01768624
Lead Sponsor
University of Sydney
Brief Summary

The primary aims of the Patient INformation about Options for Treatment (PINOT) Follow-up Study are to determine the proportions of patients, identified in the 2009 PINOT cohort that:

(i)Made the transition to home dialysis, after an initial start on center-based dialysis.

(ii)Commenced dialysis, or a time-limited trial of dialysis within 3 years, after confirmed plans for conservative care.

The hypotheses to be tested in the PINOT follow-up study are:

1. 50% of stage 5 chronic kidney disease patients who plan for home dialysis do not commence home dialysis within 3 years, and instead remain on centre-based haemodialysis; and,

2. less than 15% of stage 5 chronic kidney disease patients who plan for conservative care commence dialysis within 3 years.

Detailed Description

The secondary aims of the follow-up study include:

(i) To assess the primary reasons patients did not transition to home dialysis, in the planned home dialysis group.

(ii)To compare 3 and 5 year survival rates among patients who commenced conservative care and patients who commenced renal replacement therapy.

(iii) To assess the types of dialysis utilisation over a 5 year time period among the total cohort of patients.

(iv)To determine how renal palliative care services were engaged for conservative care patients, and document the patient's place of death (i.e. hospital, hospice, home with community palliative care).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
721
Inclusion Criteria
  • Adults and children with end stage kidney disease (eGFR <15 ml/min) who commenced renal replacement therapy or conservative care in Australia between July and September 2009
Exclusion Criteria
  • Patients returning to dialysis after a failed transplant,
  • Patients with acute renal failure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Stage 5 chronic kidney diseasedialysis, kidney transplantPatients receiving home hemodialysis Patients receiving home peritoneal dialysis Patients receiving center-based hemodialysis Patients who had a pre-emptive kidney transplant Patients who planned for renal conservative care
Primary Outcome Measures
NameTimeMethod
The proportion of patients who make the transition to home dialysis, after an initial start on center-based hemodialysis.5 years
Secondary Outcome Measures
NameTimeMethod
The proportion of patients who commence dialysis, or have a time-limited trial of dialysis within 3 and 5 years, after a confirmed plan for conservative care.5 years

Trial Locations

Locations (2)

University of Sydney

🇦🇺

Sydney, New South Wales, Australia

University of Oxford

🇬🇧

Headington, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath